U.S. Court of Appeals for the Federal Circuit, 2022

Boston Scientific v. Nevro Corp.

Boston Scientific v. Nevro Corp.
U.S. Court of Appeals for the Federal Circuit · Decided March 10, 2022

Boston Scientific v. Nevro Corp.

Opinion

Case: 21-1775 Document: 37 Page: 1 Filed: 03/10/2022

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ BOSTON SCIENTIFIC NEUROMODULATION CORP., Appellant v. NEVRO CORP., Appellee ______________________ 2021-1775 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2019- 01284. ______________________ JUDGMENT ______________________ Z.W. JULIUS CHEN, Akin Gump Strauss Hauer & Feld LLP, Washington, DC, argued for appellant. Also repre- sented by PRATIK A. SHAH; MICHAEL P. KAHN, New York, NY; DAVID A. CAINE, Arnold & Porter Kaye Scholer LLP, Palo Alto, CA; MATTHEW WOLF, Washington, DC.

RYAN C. MORRIS, Sidley Austin LLP, Washington, DC, argued for appellee. Also represented by THOMAS ANTHONY BROUGHAN, III; CHING-LEE FUKUDA, SHARON LEE, New Case: 21-1775 Document: 37 Page: 2 Filed: 03/10/2022

York, NY; JON WRIGHT, Sterne Kessler Goldstein & Fox, PLLC, Washington, DC. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (MOORE, Chief Judge, CHEN and HUGHES, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

March 10, 2022 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.